Meta-Analysis of Lymphocytes in Schizophrenia: Clinical Status and Antipsychotic Effects
Miller BJ, Gassama B, Sebastian D, Buckley P, Mellor A. Meta-Analysis of Lymphocytes in Schizophrenia: Clinical Status and Antipsychotic Effects. Biological Psychiatry 2012, 73: 993-999. PMID: 23062357, PMCID: PMC3816144, DOI: 10.1016/j.biopsych.2012.09.007.Peer-Reviewed Original ResearchConceptsCD4/CD8 ratioFirst-episode psychosisAcute exacerbationAntipsychotic treatmentCD8 ratioClinical statusDrug-naïve first-episode psychosisTrait markerImmune cell parametersState-related markersImmune system dysfunctionCross-sectional studyPotential confounding factorsLongitudinal studyMononuclear phagocytic systemMore longitudinal studiesLymphocyte abnormalitiesTotal lymphocytesClinical featuresAntipsychotic effectsAntipsychotic medicationSystem dysfunctionBlood lymphocytesInclusion criteriaReference lists80. Meta-analysis of monocytes and lymphocytes in schizophrenia: Clinical status and antipsychotic effects
Miller B, Gassama B, Sebastian D, Buckley P, Mellor A. 80. Meta-analysis of monocytes and lymphocytes in schizophrenia: Clinical status and antipsychotic effects. Brain Behavior And Immunity 2012, 26: s22-s23. DOI: 10.1016/j.bbi.2012.07.104.Peer-Reviewed Original ResearchFirst-episode psychosisAcute psychosisAntipsychotic treatmentCD4 levelsClinical statusTrait markerCD4/CD8 ratioImmune cell abnormalitiesImmune cell parametersState-related markersCD4/CD8Potential confounding factorsEffect sizeCD8 ratioImmune dysfunctionAntipsychotic effectsAntipsychotic medicationInclusion criteriaCell abnormalitiesReference listsStable outpatientsConfounding factorsPub MedState markerMajority of studies